Category: Gene Therapy
Gene Therapy market research reports by Frost & Sullivan
-
Pipeline Assessment for Cardiovascular Diseases
Pipeline Assessment for Cardiovascular Diseases Advanced Drug Modalities Fuel Cardiovascular Therapeutics Future Growth Potential Globally, CVD is the leading cause of death, with resurgence in higher-income countries and higher prevalence in low- and middle-income countries. While there have been m ... Read More
-
CGT Research Outlook and Technology Growth Opportunities
CGT Research Outlook and Technology Growth Opportunities CGT Landscape Assessment The CGT landscape has evolved extensively over the past decade. More than 80 CGT products have been commercialized globally, with 34 FDA-approved cell and gene therapies in 2023 alone. The rise in product pipelines and ... Read More
-
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022
Frost Radar™: Cell and Gene Therapy Contract Development and Manufacturing Organizations, 2022 As cell and gene therapy (CGT) moves from ultra-rare indications to more common indications, manufacturing capabilities will have to expand to support the commercial requirements of these diseases. Contrac ... Read More
-
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis
Emerging Therapeutics for Rare Neuromuscular Diseases: Pipeline Analysis Muscle weakness, cramps, and impaired musculoskeletal functions that occur due to rare defects in nerve and muscle cells characterize neuromuscular disorders (NMDs). The disorders are largely classified as motor neuron diseases ... Read More
-
Technology Growth Opportunities for Exosome-Mediated Drug Delivery
Technology Growth Opportunities for Exosome-Mediated Drug Delivery Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over ... Read More
-
Global Cell and Gene Therapy (CGT) Growth Opportunities
Global Cell and Gene Therapy (CGT) Growth Opportunities This Frost & Sullivan study examines the global cell and gene therapy (CGT) market. It highlights revenue forecasts and key growth opportunities for CGT market participants based on the evolution of their business models and strategic approache ... Read More
Research Assistance
